A Phase I Study of the Safety and Immunogenicity of BCG (Bacille Calmette-Guerin) Vaccine Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG
Phase of Trial: Phase I
Latest Information Update: 18 Apr 2008
At a glance
- Drugs BCG vaccine (Primary)
- Indications Tuberculosis
- Focus Adverse reactions; Pharmacodynamics
- 18 Apr 2008 New trial record.